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Abstract 
This review gives an overview of current knowledge on hyperoxia pathophysiology and examines experimental and 
human evidence of hyperoxia effects after cardiac arrest. Oxygen plays a pivotal role in critical care management as 
a lifesaving therapy through the compensation of the imbalance between oxygen requirements and supply. How‑
ever, growing evidence sustains the hypothesis of reactive oxygen species overproduction‑mediated toxicity during 
hyperoxia, thus exacerbating organ failure by various oxidative cellular injuries. In the cardiac arrest context, evidence 
of hyperoxia effects on outcome is fairly conflicting. Although prospective data are lacking, retrospective studies and 
meta‑analysis suggest that hyperoxia could be associated with an increased mortality. However, data originate from 
retrospective, heterogeneous and inconsistent studies presenting various biases that are detailed in this review. There‑
fore, after an original and detailed analysis of all experimental and clinical studies, we herein provide new ideas and 
concepts that could participate to improve knowledge on oxygen toxicity and help in developing further prospec‑
tive controlled randomized trials on this topic. Up to now, the strategy recommended by international guidelines on 
cardiac arrest (i.e., targeting an oxyhemoglobin saturation of 94–98 %) should be applied in order to avoid deleterious 
hypoxia and potent hyperoxia.
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Background
Oxygen has a pivotal role in medicine as a lifesav-
ing therapy in many emergency situations. In order to 
avoid hypoxia-related mortality and morbidity, oxygen 
is delivered in acute care situations in a liberal way, even 
if hypoxia is not confirmed. However, as every medica-
tion, experimental and clinical studies have highlighted 
some physiological potent side effects of high oxygen 
tension that could worsen outcome [1]. Cardiac arrest 
is the archetypal situation given the imperious need 
of rapid oxygen delivery in organs. Nevertheless, this 
global ischemia–reperfusion syndrome produces high 
amounts of reactive oxygen species that could be signifi-
cantly increased by high oxygen tension. Thus, hyper-
oxia in the post-resuscitation context of cardiac arrest 
is an important topic. Despite several experimental and 
clinical studies, this subject remains at the center of 
conflicting results with insufficient body of evidences. 
We screened PubMed, Embase and Cochrane databases 
using the following keywords with various combina-
tions: “cardiac arrest,” “oxygen,” “oxidative stress” and 
“hyperoxia.” Pediatric data concerning oxygen manage-
ment during and after cardiac arrest were neither listed 
nor analyzed given differences in etiologies, management 
and outcome between adult and pediatric patients resus-
citated from cardiac arrest. We herein provide an over-
view of the present knowledge of the pathophysiological 
effects of oxygen, review experimental and clinical stud-
ies and develop some concepts that could be beneficial 
for further studies.
Pathophysiology of oxygen and hyperoxia
Hyperoxia occurs when the partial pressure of intraal-
veolar oxygen exceeds normal breathing conditions, thus 
leading to hyperoxemia, which is defined by an increased 
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arterial O2 partial pressure. Oxygen concentration in the 
blood is a combination of 3 main parameters and the sum 
of the dissolved oxygen and the hemoglobin-bound oxy-
gen, defined by the following equation:
where OBC: oxygen blood concentration (mL of oxy-
gen per liter of blood); 1.34: oxygen-carrying capacity 
of hemoglobin (mL of oxygen per gram of hemoglobin), 
[Hb]: hemoglobin, [SaO2]: hemoglobin oxygen satura-
tion, [Kh]: solubility coefficient of oxygen, [PaO2]: arterial 
oxygen partial pressure.
At normal pH and normal temperature, increased O2 
breathing raises the amount of dissolved O2 without 
modifying the close to 100 % hemoglobin saturation given 
the sigmoid-shaped hemoglobin to oxygen dissociation 
curve (Fig.  1). If the Henry’s law states a linear relation 
between arterial oxygen partial pressure and oxygen solu-
bility, temperature is a main parameter influencing the 
solubility coefficient parameter Kh. For instance, using 
the work by Battino et al. [2] and the Van’t Hoff equation, 
Kh (37 °C) = 0.0031 whereas Kh (33 °C) = 0.0084. There-
fore, hypothermia increases amounts of oxygen dissolved 
in the blood (Fig.  1). Moreover, several factors affect 
the dissociation curve of oxyhemoglobin such as tem-
perature, pH (Borr effect), PaCO2 (Haldane effect) and 
2,3-biphosphoglyceric acid [3]. A left shift of the curve 
that means a higher oxygen affinity of hemoglobin is 
induced by hypothermia, hypocarbia and alkalosis. This 
OBC = [Hemoglobin− bound oxygen]
+ [Dissolved oxygen]
OBC = (1.34 × [Hb]× [SaO2])+ (Kh× [PaO2])
arterial accumulation of dissolved oxygen is supposed 
to exert deleterious effects through various mechanisms 
that are intricately linked: reactive oxygen species (ROS) 
overproduction, pulmonary toxicity, cardiac and neuro-
logical affects.
ROS are unstable and highly reactive molecules, par-
ticipating in a broad spectrum of cellular events such as 
production of inflammation mediators, intracellular mes-
sengers or anti-infectious effectors. In mammalian, ROS 
can be of endogenous or exogenous origin (radiation, 
pollution, drugs, medication, smoking). Under physiolog-
ical condition, ROS are produced by the respiratory chain 
in mitochondria or by enzymatic reactions.
Toxicity of ROS consists essentially in lipid peroxida-
tion, protein oxidation and DNA damages. Lipid peroxi-
dation, when affecting intra- or extracellular membranes, 
leads to enzyme inactivation, thiols oxidation and mito-
chondrial respiratory chain inhibition [4]. Protein oxi-
dation confers resistance to proteolysis, mostly by 
aggregation [5]. Toxicity of ROS with regard to DNA is 
dominated by cellular cycle modification, apoptosis and 
carcinogenesis [6].
The defenses developed to minimize, prevent and 
repair injuries caused by oxidative stress include enzy-
matic ROS removal (superoxide dismutase, catalase and 
glutathione peroxidase) and the non-enzymatic quench-
ing of ROS by antioxidant (glutathione, albumin, A and 
E vitamin and thiols) [7]. Mechanisms involved in cell 
death induced by high oxygen tension include apopto-
sis, necrosis or mixed-mechanisms phenotype, depend-
ing on the cell type investigated. As oxygen is one of the 
Fig. 1 Hypothermia increases quantity of dissolved oxygen in blood. (a) + (b) The gray area under the curve represents amounts of hemoglobin‑
bound oxygen, and the black area under the curve represents quantity of dissolved oxygen. If a 33 °C temperature is associated with a leftward shift 
of the oxyhemoglobin curve when compared to a 37 °C central temperature, hypothermia (b) increases dissolved oxygen quantity in blood. For 
instance, there is a 2.7‑fold increase in dissolved quantity of oxygen between 33 and 37 °C
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main modulating factors of ROS production, hyperoxia 
appears to be a major provider of ROS overproduction, 
particularly in the inflammatory context of cardiac arrest, 
thus leading to an imbalance in the oxidative status.
Hyperoxia is known to exert toxic pulmonary effects 
through pulmonary gas exchange impairment or direct 
pulmonary toxicity. The alteration in gas exchanges is 
driven by the inhibition of hypoxic pulmonary vaso-
constriction and by the “adsorption atelectasis” that 
increases intrapulmonary right-to-left shunt. Direct pul-
monary toxicity, so-called Lorrain–Smith effect, consists 
in ROS-related direct toxicity on alveolar capillary bar-
rier and leads to lung passageways congestion and hem-
orrhagic pulmonary edema [8].
Hyperoxia decreases cardiac output due to both a 
drop of heart rate [9] and a rise in vascular resistance 
[10]. Supra-physiological oxygen tensions also alter the 
microperfusion through a decreased capillary perfusion 
[11] and the systemic perfusion. This hyperoxia-induced 
vasoconstriction may result from a fall in NO bioavail-
ability [12], with a potential contribution of ROS [13].
Hyperoxia possibly has toxic effects on the central 
nervous system, the so-called Paul Bert effect, which 
could reach its climax with tonic–clonic seizures [14]. 
This deleterious effect is particularly reported to occur in 
supra-atmospheric pressure such as hyperbaric chambers 
or diving and possibly related to ROS formation [15].
Experimental evidences in the cardiac arrest 
context
Various models with significant disparities
Various evidences from animal studies sustain the ration-
ale for brain lesions after hyperoxic resuscitation. These 
studies compare the administration of hyperoxic to 
lower concentration of oxygen following resuscitation on 
neurological, histological and neurochemical outcome 
(Table  1). However, these studies show significant dis-
parities. First, experimental models use three different 
animals (i.e., dogs, rats and pigs) with various resuscita-
tion protocols. Second, even if most of the cardiac arrests 
are induced by electrically induced ventricular fibrilla-
tion, diverse cardiac arrest models are used. For instance, 
the use of asphyxia by Lipinski et al. may strongly influ-
ence response to oxygen during and after cardiopulmo-
nary resuscitation. Thus, given the differences in animal 
species and cardiac arrest models, Pilcher et al. recently 
performed a meta-analysis of several studies in order to 
evaluate effects of hyperoxia on neurological outcome 
after cardiac arrest [16]. Meta-analysis of six studies with 
95 animals revealed that 100  % FiO2 is associated with 
worse neurological outcome with a standardized mean 
difference of −0.64 (95 % CI −1.06 to −0.22). However, 
this result should be considered with caution given the 
heterogeneity of models and the small size of the overall 
population.
A body of evidence highlighting the role of oxidative stress
Within a broad spectrum of cellular events, impaired 
cerebral enzymes appear to play a pivotal role in 
ischemia–reperfusion brain injury by oxidative molecu-
lar mechanisms. Instead of producing amounts of use-
ful aerobic energy metabolites, anaerobic glycolysis 
observed during ischemia reperfusion condition pro-
duces excessive lactate, thus decreasing ATP produc-
tion. Vereczki et al. investigated the effects of normoxic 
resuscitation on loss of pyruvate dehydrogenase enzyme 
(which induces the decarboxylation of pyruvate into 
NADH and acetyl coenzyme A) and neuronal death using 
a dog model of electrical cardiac arrest. The post-cardiac 
arrest hyperoxic ventilation led to higher loss of pyruvate 
dehydrogenase enzyme and to an increase in hippocam-
pal neuronal death [17]. To go further, Richards et  al. 
examined the hypothesis that the initial hippocampal 
neuronal loss could be related to a preferential decrease 
in aerobic metabolism when compared to the cortex. 
They investigated the pyruvate dehydrogenase enzyme 
activity decrease under hyperoxic condition into an elec-
trical ventricular fibrillation dog model of cardiac arrest. 
Using carbon isotypes inclusion and spectroscopy, they 
found that dogs resuscitated with high levels of oxygen 
(100 vs. 21–30  % of inspired oxygen) had a decrease in 
PDH activity [18, 19]. This study seems to suggest a rela-
tion between increased oxidative stress and hyperoxia 
resuscitation in cardiac arrest.
Relevance of experimental models
Most of all, experimental studies are not a good reflec-
tion of current standard of care in cardiopulmonary 
resuscitation. First, some animals are anesthetized and 
mechanically ventilated before cardiac arrest. There-
fore, hyperoxia is sometimes induced prior to cardiac 
arrest and administration of high-inspired oxygen frac-
tion has an impact on further analysis. Second, whereas 
temperature is nowadays widely admitted to influence 
oxygenation parameters, no study is performed under 
therapeutic hypothermia and central body tempera-
ture management details are scarce. Third, neurological 
examination is performed in a time frame ranging from 
2  h to 5  days. Indeed, data are lacking on neurological 
long-term outcome.
Preclinical data available in animals are characterized 
by a large disparity in species, in arrest mechanisms and 
in resuscitation protocols. Furthermore, the discrepancy 
between recorded effects of hyperoxia on neurologi-
cal outcome does not provide a clear answer. Mecha-
nisms need to be elucidated, particularly the relationship 
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between neurological damages following resuscitation 
and ROS overproduction within cerebral tissue under 
hyperoxic conditions. Finally, the clinical significance of 
these different experimental models studies is unclear.
Hyperoxia and cardiac arrest in humans
Based on the observational data from Norway that report 
a better outcome in centers that did not use hyperoxygen-
ation during CPR [20], the hypothesis of the neurological 
detrimental effects of hyperoxia after cardiopulmonary 
resuscitation was first investigated prospectively in a 
small study including 28 patients, randomized to be ven-
tilated with either 30 or 100 % inspired oxygen after out-
of-hospital cardiac arrest. Using neuron-specific enolase 
(NSE) 24 h after resuscitation as a specific marker of neu-
ronal injury, the authors found a statistically significant 
increase in this enzyme within a subgroup of patients 
not treated with therapeutic hypothermia, thus suggest-
ing both neurological deleterious effects of hyperoxia and 
putative beneficial effects of hypothermia on hyperoxia 
damages [21]. Regrettably, this trial does not incorporate 
enough patients to appraise neurological outcome or sur-
vival. Moreover, a recent randomized controlled feasibil-
ity trial failed to safely titrate oxygen in the pre-hospital 
period [22]. Therefore, most of the data are provided by 
retrospective studies (Table 2).
Two main retrospective studies with conflicting results
Two recently published articles mainly dominate ret-
rospective studies in humans. First, Kilgannon et  al. 
reported a retrospective cohort of patients extracted 
from an American database consolidating 120 centers 
(Project IMPACT) [23]. In multivariate analysis, expo-
sition to hyperoxia on mortality is associated with an 
odds ratio of 1.8 (95  % CI 1.5–2.2). On the other hand, 
Bellomo et al. reported a retrospective cohort of patients 
extracted from an Australian and New Zealand data-
base clustering 125 centers [24]. In multivariate analy-
sis, exposition to hyperoxia was associated with an odds 
ratio of 1.2 (95 % CI 1.1–1.6), but no longer using a Cox 
proportional hazard model and when adjusted on FiO2. 
Major differences in the definition and in the analysis of 
hyperoxia may explain these conflicting results.
An important variability in hyperoxia definition
In order to ensure comparison after the work by Kil-
gannon et  al., most of the studies define hyperoxia as a 
PaO2 higher or equal to 300  mmHg. This definition is 
based a priori and arbitrarily on an experimental study 
evaluating the effect of hypoxemic reperfusion on brain 
histopathological changes in the pig [25]. There is no 
physiological evidence in humans to support the use of 
this cutoff value, and the use of a single value may under 
or overestimate hyperoxia incidence. Moreover, a defini-
tion of groups using PaO2 presupposes a threshold effect 
of oxygen and eliminates a dose-dependant effect. This 
point has been investigated in three studies. Analyz-
ing PaO2 as a continuous variable, Kilgannon et  al. and 
Janz et al. found in multivariate analysis that high levels 
of PaO2 were associated with an increased mortality (OR 
1.69; 95 % CI 1.56–2.07 and OR 1.4; 95 % CI 1.02–2.01, 
respectively) [26, 27]. Interestingly, these two studies 
had similar overall mortality (54 and 55 %, respectively). 
The third study found no association between PaO2 lev-
els of exposure and the neurological status at 12 months 
as the main outcome measure [28]. These results sup-
port the hypothesis of a dose-dependant association 
between supra-normal oxygen tension and outcome. 
However, various precisions are lacking in the work done 
by Kilgannon et al., for instance cardiac arrest precisions 
(according to Utstein style) like the cause of death, neuro-
logical outcome or ventilation parameters, and thus may 
participate to overestimation of oxygen role in mortality.
In addition, the value of PaO2 of interest is not clearly 
defined in the literature. In the first study published by 
Kilgannon et al., hyperoxia was defined according to the 
first blood gas analysis available within the first 24 h after 
intensive care unit admission; some studies analyze the 
highest PaO2 in the first 24 h [26, 27, 29], whereas in the 
studies reported by Bellomo et al. and Ihle et  al. hyper-
oxia was defined using the “worst” blood gas analysis 
within the first 24  h [24, 30]. These variations seem to 
affect hyperoxia prevalence, which is, for instance, rang-
ing in all studies from 2.7 to 41 % and may thus introduce 
bias for further analysis on mortality.
Influence of hypothermia on oxygen status 
during post-cardiac arrest resuscitation
It is now well established that temperature mainly influ-
ences ventilation and oxygenation parameters in patients. 
Hypothermia induces a right shift of the oxygen disso-
ciation curve, decreases oxygen amounts released and 
increases carbon dioxide solubility [31]. Precisions on 
temperature are lacking in some studies [30, 32], whereas 
various proportions of patients are treated with thera-
peutic hypothermia in others (even if the induced or 
spontaneous nature of this hypothermia is not clearly 
indicated) ranging from 6  % [23] to 80  % [33]. Moreo-
ver, methodological details regarding temperature cor-
rections of arterial blood gas are missing in most of the 
studies. To address this concern, two studies investi-
gated effects of oxygenation status on mortality under 
hypothermia conditions. Once again, analysis of PaO2 
differs between these two studies and thus limits com-
parison: Janz et al. use the highest PaO2 [27], whereas Lee 
et al. use the mean PaO2 using 8 arterial blood gas from 
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ROSC to rewarming [34]. Therefore, using the previously 
reported cutoff value of 300  mmHg, 1.1  % of patients 
presented hyperthermia in the study by Lee et  al. while 
about 30 % of patients were in the hyperoxia group in the 
study by Janz et al. This issue may have a major impact on 
overall mortality in most of the studies given the various 
proportions of patients under hypothermia. For instance, 
difference in mortality reported by Kilgannon et al. may 
be overestimated given the 6 % of patients with a central 
temperature under 34 °C within the first 24 h when com-
pared to the 66 % of patients under the same condition in 
the work by Elmer et al. [35].
Oxygen exposition after cardiac arrest: the crucial period
Another problem of interest is the time point of hyper-
oxia exposure, which can lead to misclassification of 
patients. Assuming the deleterious effect of exposition 
to supra-normal oxygen tension after cardiac arrest, 
precise time point when oxygen may have a detrimental 
effect remains unclear. Experimental evidence supports 
the assumption that early hyperoxia should be more per-
nicious than late hyperoxia [36] and that oxidant injury 
occurs rapidly after cardiac arrest [37]. However, results 
are different in humans. Indeed, one study evaluated the 
impact of PaO2 levels during cardiopulmonary resuscita-
tion on cerebral performance status after hospital admis-
sion. In this study, 28 % of patients survived with cerebral 
performance category CPC 1 or 2 in the hyperoxia group 
(PaO2 during CPR >300  mmHg) whereas 23 and 14  % 
of patients survived with a CPC 1 or 2 in the normoxia 
and hypoxia group, respectively [32]. Nevertheless, these 
interesting results should be taken cautiously given the 
higher rate of hospital admission in the hyperoxia group 
(83.3 vs. 50.6 % in the normoxia group and 18.8 % in the 
hypoxia group) that could indicate a better initial prog-
nosis of hyperoxic patients.
Recently, three meta-analyses pooled observational 
studies studying the relationship between hyperoxia 
and outcomes in post-cardiac arrest [38–40]. Hyperoxia 
appears to be correlated with increased intrahospital 
mortality. However, these results must be interpreted 
cautiously given the heterogeneity and the limited sam-
ple size in analyzed studies. Moreover, as highlighted by 
the authors, they reconstructed OR when not provided 
and some patients are overlapped within the population 
studied by Bellomo et al. [24] and Ihle et al. [30] using the 
ANZICS database.
How to think out of the box?
Given their short life, ROS cellular damages require the 
postulate of an increased oxygen tension within the dam-
aged tissue. However, arterial PaO2 is possibly not an 
accurate estimate of tissular oxygen delivery, particularly 
when cerebral blood flow is decreased. Using a swine 
model of cardiac arrest, Rossi et  al. found a negligible 
improvement of cerebral oxygen consumption under 
hyperoxia condition during cerebral blood flow reduction 
mimicking CPR [41]. Therefore, a regional cerebral tis-
sue oxygenation monitoring before and after ROSC could 
improve the comprehension of hyperoxia mechanisms.
Most of the clinical studies focus on intrahospital 
mortality or on cerebral performance status as the main 
outcome measure for hyperoxia exposure after cardiac 
arrest and hypothesize an increased ROS production-
mediated process. However, outcome may be related to 
other mechanisms. For instance, although a causal role 
has never been highlighted, hyperoxia is recognized to 
induce pulmonary dysfunction and may affect patient 
outcome after cardiac arrest. Only one recent study 
investigated whether high levels of oxygen exposure after 
cardiac arrest contribute to pulmonary dysfunction. They 
found no relation between pulmonary compliance and 
higher exposure to oxygen in the first hours [42]. Nev-
ertheless, whether hyperoxia may participate to ventila-
tor-acquired pneumonia occurrence or could increase 
cardiac dysfunction remains unknown and should be 
investigated in further studies.
Even if oxidative stress is a well experimentally docu-
mented mechanism of toxicity in ischemia–reperfusion, 
evidence in the cardiac arrest context is scarce. Only 
one study reports decreased amounts of derivatives of 
reactive oxygen metabolites but also a decreased global 
antioxidant capacity of blood plasma after cardiac arrest 
under therapeutic hypothermia [43]. Unfortunately, base-
line oxidative status is not compared to control popula-
tion and therefore cannot be evaluated. Cardiac arrest is 
Table 3 Ongoing studies related to hyperoxia in the cardiac arrest context
Study Title Identifier Location Characteristics Objective
EXACT study Reduction of oxygen 
after cardiac arrest
NCT02499042 Australia Prospective randomised 
controlled trial
Evaluate the feasibility of paramedic titration of 
oxygen delivery in adults resuscitated from 
cardiac arrest
REOX study Reoxygenation after 
cardiac arrest
NCT01881243 USA Prospective  
observational study
Testing the association between hyperoxia 
exposure after resuscitation from cardiac 
arrest and outcome and oxidative tress status
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strongly supposed to induce ROS overproduction, but 
effects on antioxidant defenses are poorly documented, 
so as the levels of ROS production when compared to 
other populations of patients such as cerebral trauma 
or cerebral ischemia. Considerations on these aspects 
should be part of the analysis on hyperoxia toxicity after 
cardiac arrest and could therefore lead to reconsider and 
revisit the current concept of oxygen toxicity after car-
diac arrest.
Although PaO2 provided by arterial blood gas is the 
only measurement of oxygen concentration in blood, 
dissolved oxygen is only responsible for ROS produc-
tion. Dissolved oxygen quantification should therefore 
be the main parameter assessed in studies. Moreover, 
estimation of dissolved oxygen in blood should take into 
account temperature-related variation. For instance, 
decreasing central temperature from 37 to 33 °C is asso-
ciated with a 2.7-fold increase in dissolved oxygen in the 
blood, which might increase oxidative damages.
Conclusion
Cardiac arrest is a cataclysmic form of global ischemia–
reperfusion affecting all organs, leading to reconsider 
the direct toxicity of hyperoxia on neurological out-
come and mortality, considering ROS-mediated inju-
ries observed in animal models. Many questions are 
still unsolved: Assuming an imbalance in oxidative 
stress equilibrium, is there a decrease in antioxidative 
defenses, an increase in ROS amounts or both? What is 
the role of nitrogen species? Does dissolved oxygen play 
a significant role?
Variability in primary outcome in human studies high-
lights the difficulties encountered by authors in examin-
ing outcome (Table 3). It is important to note that none 
of the animal studies establish any repercussion of hyper-
oxia on survival. Given the suspected pathophysiology of 
hyperoxia toxicity and the evidence from animal experi-
mental studies, this problem emphasizes the importance 
of focusing also on neurological damages induced by high 
oxygen tension. We suggest that a well-designed prospec-
tive study should assess whether receiving increasing 
values of arterial oxygen partial pressure (using temper-
ature-corrected oxygen dissolved in blood as a continu-
ous variable), as soon as possible after ROSC, is or not 
associated with a difference in oxidative stress imbalance 
and outcome.
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